Quality First International

Extended Deadline for Registration of Medical Devices in Italy

London, 19 January 2009

Quality First International previously issued an alert to all medical device companies intending to sell their medical device in Italy beyond 31 December 2008: Italy introduced various changes in healthcare regulations, among which is the need for any medical device placed on the Italian market to be registered on a central, coded database according to two Italian Decrees issued in February 2007 and on 20 March 2007 by the Italian Ministry of Health.

Recently, the deadline for registration has been extended to 30 April 2009 according to Order of 23 December 2008 issued by the Ministry of Health.

Registration of products can take up to a month typically and can only be accomplished by certain trained individuals appointed by the manufacturer to access, enter and edit information on the database. Quality First International is among a number of professional companies able to perform the registration and act as custodian of the licence awarded on behalf of our clients.

Coding of products will be according to an Italian system distinct from other schemes such as GMDN or UDMNS. The database is separate also from reimbursement controls in Italy. Quality First International, a regulatory consultancy that is trained and authorised by the Italian government to conduct registrations, can commence the registration on a company’s behalf speedily on receipt of instructions. The new obligations for registration complement Quality First International’s other established business programmes: the EU Authorised Representative service and Registar*.

About Quality First International (QFI)

Quality First International Limited (QFI) is a London-based medical devices consulting company specialising in solving its clients’ regulatory, technical and compliance challenges to enable medical devices to enter the global marketplace. QFI provides regulatory advice, quality assurance and clinical trial services, with particular emphasis on the European, US, Japanese, Australian, Canadian and Chinese marketplaces. All submissions made by QFI have fulfilled the compliance requirements first time round, consistently. QFI clients range from start-up companies to multinational organisations, primarily developing a broad range of cutting-edge, minimally invasive and cardiovascular products and implants.

For further information, please contact:

Rachid Hattab, Tel: +44 208-221-2361 ext 202
Tom Alexandris (for US companies), Tel: +1 770-656-5513
Email: enquiries@qualityfirstint.com

For further press information, please contact:

Marija Capek, PR and Press Officer
Tel: +49 (0)621 166 2326
Email: marija@qualityfirstint.com
Web: www.qualityfirstint.com